US5981569A
(en)
*
|
1992-11-13 |
1999-11-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease
|
US5792771A
(en)
*
|
1992-11-13 |
1998-08-11 |
Sugen, Inc. |
Quinazoline compounds and compositions thereof for the treatment of disease
|
US5763441A
(en)
*
|
1992-11-13 |
1998-06-09 |
Sugen, Inc. |
Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
|
US5712395A
(en)
*
|
1992-11-13 |
1998-01-27 |
Yissum Research Development Corp. |
Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
|
US5451603A
(en)
*
|
1993-03-11 |
1995-09-19 |
Zymogenetics, Inc. |
3,4-diarylchromans for treatment of dermatitis
|
WO1995000513A1
(fr)
*
|
1993-06-25 |
1995-01-05 |
Laboratoires Upsa |
Naphtyridines antiproliferatives
|
US5416098A
(en)
*
|
1993-12-30 |
1995-05-16 |
Zymogenetics, Inc. |
Method for treating dermatitis and related conditions
|
US5700823A
(en)
*
|
1994-01-07 |
1997-12-23 |
Sugen, Inc. |
Treatment of platelet derived growth factor related disorders such as cancers
|
WO1995024190A2
(en)
*
|
1994-03-07 |
1995-09-14 |
Sugen, Inc. |
Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
|
US5721277A
(en)
*
|
1995-04-21 |
1998-02-24 |
Sugen, Inc. |
Compounds and methods for inhibiting hyper-proliferative cell growth
|
US6331555B1
(en)
|
1995-06-01 |
2001-12-18 |
University Of California |
Treatment of platelet derived growth factor related disorders such as cancers
|
US5710164A
(en)
*
|
1995-06-06 |
1998-01-20 |
American Home Products Corporation |
Diheterocyclic styryl nitriles
|
AU6112896A
(en)
*
|
1995-06-07 |
1996-12-30 |
Sugen, Inc. |
Tyrphostin-like compounds for the treatment of cell prolifer ative disorders or cell differentiation disorders
|
US5710173A
(en)
*
|
1995-06-07 |
1998-01-20 |
Sugen, Inc. |
Thienyl compounds for inhibition of cell proliferative disorders
|
US6906093B2
(en)
|
1995-06-07 |
2005-06-14 |
Sugen, Inc. |
Indolinone combinatorial libraries and related products and methods for the treatment of disease
|
US6316635B1
(en)
|
1995-06-07 |
2001-11-13 |
Sugen, Inc. |
2-indolinone derivatives as modulators of protein kinase activity
|
US5650415A
(en)
*
|
1995-06-07 |
1997-07-22 |
Sugen, Inc. |
Quinoline compounds
|
US5763470A
(en)
*
|
1995-06-07 |
1998-06-09 |
Sugen Inc. |
Benzopyran compounds and methods for their use
|
US5773459A
(en)
*
|
1995-06-07 |
1998-06-30 |
Sugen, Inc. |
Urea- and thiourea-type compounds
|
CA2222545A1
(en)
*
|
1995-06-07 |
1996-12-19 |
Sugen, Inc. |
Quinazolines and pharmaceutical compositions
|
US6147106A
(en)
*
|
1997-08-20 |
2000-11-14 |
Sugen, Inc. |
Indolinone combinatorial libraries and related products and methods for the treatment of disease
|
US5880141A
(en)
|
1995-06-07 |
1999-03-09 |
Sugen, Inc. |
Benzylidene-Z-indoline compounds for the treatment of disease
|
US7119174B2
(en)
*
|
1995-12-18 |
2006-10-10 |
Sugen, Inc. |
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
|
US6716575B2
(en)
|
1995-12-18 |
2004-04-06 |
Sugen, Inc. |
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
|
US6696448B2
(en)
|
1996-06-05 |
2004-02-24 |
Sugen, Inc. |
3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
|
US6682921B1
(en)
*
|
1996-08-21 |
2004-01-27 |
New York University |
Crystals of the tyrosine kinase domain of non-insulin receptor tyrosine kinases
|
US5854285A
(en)
*
|
1997-04-03 |
1998-12-29 |
Natpro, Inc. |
Protein kinase inhibitor
|
US6818440B2
(en)
*
|
1997-04-28 |
2004-11-16 |
Sugen, Inc. |
Diagnosis and treatment of alk-7 related disorders
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
US6316429B1
(en)
*
|
1997-05-07 |
2001-11-13 |
Sugen, Inc. |
Bicyclic protein kinase inhibitors
|
US6486185B1
(en)
|
1997-05-07 |
2002-11-26 |
Sugen, Inc. |
3-heteroarylidene-2-indolinone protein kinase inhibitors
|
US6316479B1
(en)
|
1997-05-19 |
2001-11-13 |
Sugen, Inc. |
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
|
US6228641B1
(en)
|
1997-05-20 |
2001-05-08 |
Sugen, Inc. |
Diagnosis and treatment of PTP04 related disorders
|
US6987113B2
(en)
|
1997-06-11 |
2006-01-17 |
Sugen, Inc. |
Tyrosine kinase inhibitors
|
US6342593B1
(en)
|
1997-06-11 |
2002-01-29 |
Sugen, Inc. |
Diagnosis and treatment of ALP related disorders
|
US7115710B2
(en)
*
|
1997-06-11 |
2006-10-03 |
Sugen, Inc. |
Diagnosis and treatment of PTP related disorders
|
US6388063B1
(en)
*
|
1997-06-18 |
2002-05-14 |
Sugen, Inc. |
Diagnosis and treatment of SAD related disorders
|
US6051593A
(en)
|
1997-06-20 |
2000-04-18 |
Sugen, Inc. |
3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors
|
US6130238A
(en)
*
|
1997-06-20 |
2000-10-10 |
Sugen, Inc. |
3-(cyclohexanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors
|
US6313158B1
(en)
|
1997-06-20 |
2001-11-06 |
Sugen, Inc. |
Bioavailability of 3-heteroarylidenyl-2-indolinones active as protein tyrosine kinase inhibitors
|
US6114371A
(en)
*
|
1997-06-20 |
2000-09-05 |
Sugen, Inc. |
3-(cyclohexanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors
|
US6235769B1
(en)
|
1997-07-03 |
2001-05-22 |
Sugen, Inc. |
Methods of preventing and treating neurological disorders with compounds that modulate the function of the C-RET receptor protein tyrosine kinase
|
WO1999007701A1
(en)
|
1997-08-05 |
1999-02-18 |
Sugen, Inc. |
Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors
|
US20040067531A1
(en)
*
|
1997-08-20 |
2004-04-08 |
Sugen, Inc. |
Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
|
ATE281834T1
(de)
*
|
1997-09-26 |
2004-11-15 |
Zentaris Gmbh |
Azabenzimidazol-verbindungen zur modulation der serin/threonin protein-kinase funktion
|
US6133305A
(en)
|
1997-09-26 |
2000-10-17 |
Sugen, Inc. |
3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity
|
UA71555C2
(en)
|
1997-10-06 |
2004-12-15 |
Zentaris Gmbh |
Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
|
US6225346B1
(en)
|
1997-10-24 |
2001-05-01 |
Sugen, Inc. |
Tyrphostin like compounds
|
AU2237899A
(en)
*
|
1998-01-21 |
1999-08-09 |
Sugen, Inc. |
Human orthologues of wart
|
US6531502B1
(en)
|
1998-01-21 |
2003-03-11 |
Sugen, Inc. |
3-Methylidenyl-2-indolinone modulators of protein kinase
|
US6514981B1
(en)
*
|
1998-04-02 |
2003-02-04 |
Sugen, Inc. |
Methods of modulating tyrosine protein kinase function with indolinone compounds
|
DK1073723T3
(da)
|
1998-04-14 |
2006-01-02 |
Sugen Inc |
STE20-relaterede proteinkinaser
|
US6569868B2
(en)
|
1998-04-16 |
2003-05-27 |
Sugen, Inc. |
2-indolinone derivatives as modulators of protein kinase activity
|
SK287132B6
(sk)
|
1998-05-29 |
2009-12-07 |
Sugen, Inc. |
Farmaceutická kompozícia obsahujúca pyrolom substituovaný 2-indolinón, súprava obsahujúca uvedenú kompozíciu a použitie pyrolom substituovaného 2-indolinónu
|
US7354894B2
(en)
|
1998-08-18 |
2008-04-08 |
The Regents Of The University Of California |
Preventing airway mucus production by administration of EGF-R antagonists
|
NZ509271A
(en)
|
1998-08-18 |
2003-10-31 |
Univ California |
Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
|
EP1117397A1
(de)
|
1998-08-31 |
2001-07-25 |
Sugen, Inc. |
Geometrisch verhinderte 2-indolinonderivate als modulatoren der protein kinase aktivität
|
EP1109823B1
(de)
|
1998-09-08 |
2005-11-16 |
Agouron Pharmaceuticals, Inc. |
Modifikationen des vegf-rezeptor-2 proteins und verfahren zu seiner verwendung
|
US6680335B2
(en)
|
1998-09-28 |
2004-01-20 |
Sugen, Inc. |
Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
|
US6689806B1
(en)
|
1999-03-24 |
2004-02-10 |
Sugen, Inc. |
Indolinone compounds as kinase inhibitors
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
US20030162223A1
(en)
*
|
1999-10-22 |
2003-08-28 |
Lowery David E. |
Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
|
US6835546B1
(en)
*
|
1999-10-22 |
2004-12-28 |
Pharmacia & Upjohn Company |
Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
|
US7364866B2
(en)
*
|
1999-10-22 |
2008-04-29 |
Pharmacia & Upjohn Company |
Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
|
US20030082534A1
(en)
*
|
1999-11-16 |
2003-05-01 |
Peter Lind |
Novel G protein-coupled receptors
|
EP1237909A2
(de)
*
|
1999-11-16 |
2002-09-11 |
PHARMACIA & UPJOHN COMPANY |
Menschliche g-protein gekoppelte rezeptoren
|
US6878733B1
(en)
|
1999-11-24 |
2005-04-12 |
Sugen, Inc. |
Formulations for pharmaceutical agents ionizable as free acids or free bases
|
MXPA02007632A
(es)
*
|
2000-02-07 |
2004-08-23 |
Abbott Gmbh & Co Kg |
Derivados de 2-benzotiazolil urea y su uso como inhibidores de proteina cinasa.
|
BRPI0108394B8
(pt)
*
|
2000-02-15 |
2021-05-25 |
Upjohn Co |
inibidores de proteína de quinase de 2-indolinona de pirrol substituído, seus sais e composições farmacêuticas compreendendo os mesmos
|
JP2003525296A
(ja)
|
2000-02-28 |
2003-08-26 |
スージェン・インコーポレーテッド |
キナーゼ阻害剤としての3−(ピロリルラクトン)−2−インドリノン化合物
|
MXPA02010759A
(es)
*
|
2000-05-02 |
2004-07-30 |
Sugen Inc |
Derivados del acido (2-oxindol-3-ilidenil) acetico y su uso como inhibidores de la proteina quinasa.
|
TWI270545B
(en)
|
2000-05-24 |
2007-01-11 |
Sugen Inc |
Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
|
JP2003535847A
(ja)
*
|
2000-06-02 |
2003-12-02 |
スージェン・インコーポレーテッド |
蛋白質キナーゼ/ホスファターゼ阻害剤としてのインドリノン誘導体
|
EP1296975A1
(de)
|
2000-06-30 |
2003-04-02 |
Sugen, Inc. |
4-heteroaryl-3-heteroarylidenyl-2-indolinone und ihre anwendung als protein kinase inhibitoren
|
US6582919B2
(en)
|
2001-06-11 |
2003-06-24 |
Response Genetics, Inc. |
Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates
|
US20050069976A1
(en)
*
|
2001-02-14 |
2005-03-31 |
Peter Lind |
Protein-coupled receptor
|
AR042586A1
(es)
|
2001-02-15 |
2005-06-29 |
Sugen Inc |
3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
|
MXPA03008560A
(es)
*
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
AR036042A1
(es)
|
2001-05-30 |
2004-08-04 |
Sugen Inc |
Derivados aralquilsufonil-3-(pirrol-2-ilmetiliden)-2-indolinona, sus composiciones farmaceuticas y metodo para la modulacion de la actividad catalitica de una proteina quinasa
|
IL159270A0
(en)
*
|
2001-06-14 |
2004-06-01 |
Yissum Res Dev Co |
Non-myeloablative tolerogenic treatment with tyrphostins
|
CA2452159A1
(en)
*
|
2001-07-23 |
2003-02-06 |
Galileo Laboratories, Inc. |
Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
|
AR038957A1
(es)
*
|
2001-08-15 |
2005-02-02 |
Pharmacia Corp |
Terapia de combinacion para el tratamiento del cancer
|
EP1430048A1
(de)
*
|
2001-09-27 |
2004-06-23 |
Allergan, Inc. |
3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-one als kinase inhibitoren
|
US6559173B1
(en)
|
2001-09-27 |
2003-05-06 |
Allergan, Inc. |
3-(heteroarylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
|
US6642232B2
(en)
|
2001-10-10 |
2003-11-04 |
Sugen, Inc. |
3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
|
US20030199525A1
(en)
*
|
2002-03-21 |
2003-10-23 |
Hirst Gavin C. |
Kinase inhibitors
|
WO2003084951A1
(en)
*
|
2002-04-03 |
2003-10-16 |
Allergan, Inc. |
(3z) -3-(3-hydro-isobenzofuran-1-ylidene)-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
|
US6541504B1
(en)
|
2002-04-03 |
2003-04-01 |
Allergan Sales, Llc |
(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
|
US20040033949A1
(en)
*
|
2002-05-06 |
2004-02-19 |
Genentech, Inc. |
Use of VEGF for treating bone defects
|
EP2430923A1
(de)
|
2002-06-05 |
2012-03-21 |
Genentech, Inc. |
Zusammensetzungen und Verfahren zum Leberwachstum und Leberschutz
|
MXPA05001277A
(es)
|
2002-08-02 |
2005-10-06 |
Ab Science |
2-(3-aminoaril)amino-4-aril-tiazoles y su uso como inhibidores del c-kit.
|
US8450302B2
(en)
*
|
2002-08-02 |
2013-05-28 |
Ab Science |
2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
|
US6699863B1
(en)
|
2002-11-27 |
2004-03-02 |
Allergan, Inc. |
Kinase inhibitors for the treatment of disease
|
US6747025B1
(en)
*
|
2002-11-27 |
2004-06-08 |
Allergan, Inc. |
Kinase inhibitors for the treatment of disease
|
US20040186160A1
(en)
*
|
2002-12-13 |
2004-09-23 |
Sugen, Inc. |
Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors
|
AP2114A
(en)
|
2003-02-26 |
2010-03-04 |
Sugen Inc |
Aminoheteroaryl compounds as protein kinase inhibitors
|
US20040266843A1
(en)
*
|
2003-03-07 |
2004-12-30 |
Sugen, Inc. |
Sulfonamide substituted indolinones as inhibitors of DNA dependent protein kinase (DNA-PK)
|
US7157577B2
(en)
*
|
2003-03-07 |
2007-01-02 |
Sugen Inc. |
5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors
|
EP1644362A2
(de)
*
|
2003-07-02 |
2006-04-12 |
Sugen, Inc. |
Indolinonhydrazide als c-met-inhibitoren
|
EP1653946A4
(de)
*
|
2003-08-06 |
2007-04-04 |
Sugen Inc |
Geometrisch beschränkte 3-cyclopentyliden-1,3-dihydroindol-2-one als wirkungsvolle proteinkinase-hemmer
|
KR100872204B1
(ko)
|
2003-10-15 |
2008-12-09 |
오에스아이 파마슈티컬스, 인코포레이티드 |
이미다조피라진 티로신 키나제 억제제
|
CA2542909C
(en)
*
|
2003-10-23 |
2012-07-10 |
Ab Science |
2-aminoaryloxazole compounds as tyrosine kinase inhibitors
|
EP2305682A1
(de)
|
2004-04-02 |
2011-04-06 |
OSI Pharmaceuticals, Inc. |
6,6-bizyklische ringsubstituierte heterobizyklische Proteinkinasehemmer
|
MY139689A
(en)
|
2004-07-20 |
2009-10-30 |
Osi Pharm Inc |
Imidazotriazines as protein kinase inhibitors
|
EP1874305B1
(de)
|
2005-04-04 |
2014-08-27 |
AB Science |
Substituierte oxazol-derivate und ihre verwendung als tyrosin-kinase-hemmer
|
US7566721B2
(en)
*
|
2005-08-08 |
2009-07-28 |
Osi Pharmaceuticals, Inc. |
Substituted thienol[2,3-d]pyrimidines as kinase inhibitors
|
AR057960A1
(es)
|
2005-12-02 |
2007-12-26 |
Osi Pharm Inc |
Inhibidores de proteina quinasa biciclicos
|
US8575164B2
(en)
*
|
2005-12-19 |
2013-11-05 |
OSI Pharmaceuticals, LLC |
Combination cancer therapy
|
US8338415B2
(en)
|
2006-01-24 |
2012-12-25 |
Allergan, Inc. |
Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
|
US7977351B2
(en)
|
2006-03-22 |
2011-07-12 |
Allergan, Inc. |
Heteroaryl dihydroindolones as kinase inhibitors
|
CA2669704A1
(en)
|
2006-11-16 |
2008-05-22 |
Allergan, Inc. |
Sulfoximines as kinase inhibitors
|
US8558002B2
(en)
|
2006-11-16 |
2013-10-15 |
Allergan, Inc. |
Sulfoximines as kinase inhibitors
|
SG177225A1
(en)
*
|
2006-12-01 |
2012-01-30 |
Agency Science Tech & Res |
Cancer-related protein kinases
|
US8663915B2
(en)
|
2007-04-13 |
2014-03-04 |
Agency For Science, Technology And Research |
Methods of controlling tumorigenesis and diagnosing the risk thereof
|
CN101909630A
(zh)
*
|
2007-11-02 |
2010-12-08 |
新加坡科技研究局 |
预防和治疗肿瘤的方法和化合物
|
WO2009091939A1
(en)
*
|
2008-01-18 |
2009-07-23 |
Osi Pharmaceuticals, Inc. |
Imidazopyrazinol derivatives for the treatment of cancers
|
ES2396613T3
(es)
*
|
2008-05-19 |
2013-02-22 |
OSI Pharmaceuticals, LLC |
Imidazopirazinas e imidazotriazinas sustituidas
|
WO2009147682A1
(en)
*
|
2008-06-05 |
2009-12-10 |
Novotyr Therapeutics Ltd. |
Novel modulators of protein kinase signaling
|
JP2012524119A
(ja)
|
2009-04-20 |
2012-10-11 |
オーエスアイ・ファーマシューティカルズ,エルエルシー |
C−ピラジン−メチルアミンの調製
|
JP2012526138A
(ja)
*
|
2009-05-07 |
2012-10-25 |
オーエスアイ・ファーマシューティカルズ,エルエルシー |
副腎皮質癌を治療するためのosi−906の使用
|
BR112012004843A2
(pt)
|
2009-09-03 |
2019-09-24 |
Allergan Inc |
compostos como moduladores de tirosina cinase
|
US9340555B2
(en)
|
2009-09-03 |
2016-05-17 |
Allergan, Inc. |
Compounds as tyrosine kinase modulators
|
WO2011153050A1
(en)
|
2010-06-02 |
2011-12-08 |
The Trustees Of The University Of Pennsylvania |
Methods and use of compounds that bind to her2/neu receptor complex
|
WO2011153049A1
(en)
|
2010-06-02 |
2011-12-08 |
The Trustees Of The University Of Pennsylvania |
Methods and use of compounds that bind to her2/neu receptor complex
|
EP3399026A1
(de)
|
2010-06-14 |
2018-11-07 |
The Scripps Research Institute |
Neuprogrammierung von zellen für ein neues zellschicksal
|
DE102011118606A1
(de)
*
|
2011-11-15 |
2013-05-16 |
Philipps-Universität Marburg |
Stilben-Verbindungen als PPAR beta/delta Inhibitoren für die Behandlung von PPAR beta/delta-vermittelten Erkrankungen
|
WO2014033281A1
(en)
|
2012-08-31 |
2014-03-06 |
Westfaelische Wilhelms-Universitaet Muenster |
Methods and peptides for preventing and treating a bcr-abl and a c-abl associated disease
|
US9468681B2
(en)
|
2013-03-01 |
2016-10-18 |
California Institute Of Technology |
Targeted nanoparticles
|
US9770454B2
(en)
|
2013-07-14 |
2017-09-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseases
|
US10351527B2
(en)
*
|
2014-04-09 |
2019-07-16 |
The University Of British Columbia |
Binding function 3 (BF3) site compounds as therapeutics and methods for their use
|
GB201407695D0
(en)
*
|
2014-05-01 |
2014-06-18 |
Univ Montfort |
Compounds
|
EP3253733B1
(de)
|
2015-02-05 |
2020-04-29 |
TyrNovo Ltd. |
Kombinationen von irs/stat3-doppelmodulatoren und antikrebsmittel zur behandlung von krebs
|
EP3317323B1
(de)
|
2015-07-01 |
2021-05-26 |
California Institute of Technology |
Kationische schleimsäurepolymerbasierte abgabesysteme
|